Nabil Hafez, MSc, MBA, is a seasoned leader in precision medicine with 20+ years in genomics, diagnostics, and healthcare software. He led key efforts at the Broad Institute on the Human Genome Project and held leadership roles at PierianDx, Sunquest, Quest Diagnostics, and GenomeQuest. Nabil has successfully driven the global commercialization of NGS and precision oncology platforms.

Ioana Stupariu, LLM leads legal, compliance, and operations at Genomate Health, bringing 15 years of experience in project management, tech regulation and regulatory compliance. She is an advisor for deep tech startups, served as DPO for a major automotive group, and is the founder of a boutique consulting firm serving CEE tech-driven companies to comply with regulatory requirements.

Peter Filotas brings 15 years of experience in software engineering, agile development, and biotech. At Genomate Health, he leads the development of proprietary computational reasoning technology, managing teams of developers and bioinformaticians. Formerly with Oncompass Medicine, Porsche Informatik, and iWiW, Peter has built and scaled high-load systems and mission-critical healthcare software platforms.

Attila Mezes leads finance at Genomate Health, bringing decades of experience in healthcare and investment. Known for his strategic vision, he has held leadership roles at Oncompass Medicine, PwC, KBC Securities, and more. Attila’s deep expertise in financial strategy and operations supports Genomate Health’s mission to expand access to precision oncology and drive sustainable growth in healthcare innovation.

Orsolya Peter drives people and culture at Genomate Health, aligning talent strategy with the company’s mission to transform cancer care through precision oncology. With 25 years of HR leadership, including at Healcloud and GE, she brings deep expertise in scaling teams, fostering inclusion, and building high-impact, collaborative environments that empower innovation in healthcare and biotech.

Barbara Vodicska, PhD, is a biochemical engineer with deep expertise in the molecular biology of cancer. She earned her PhD at the German Cancer Research Center (DKFZ) in Heidelberg. At Genomate Health, she manages international grants and collaboration projects and leads R&D&I efforts, advancing computational reasoning solutions to optimize targeted therapy decisions in precision oncology.

Robert Doczi, PhD, is a molecular biologist with over 20 years’ experience in cellular signaling. At Genomate Health, he is involved in the development and clinical validation of a novel computational method that implements cognitive computing in precision oncology. Previously, he was a postdoctoral researcher at Vienna Biocenter (Austria), was a Marie Curie Fellow at Royal Holloway, University of London (UK), and was a principal investigator at the Hungarian Academy of Sciences.

Dora Lakatos, PhD, leads computational science at Genomate Health, applying advanced modeling and machine learning to power the company’s precision oncology platform. With a PhD in biophysics, she brings deep expertise in biomedical data analysis, tumor biology, and quantitative modeling. Her work bridges computational insight with biological relevance to drive innovation in personalized cancer care.

Dora Tihanyi leads product development at Genomate Health, bringing a unique background in info-bionics. With a BSc in Molecular Bionics and an MSc in Info-Bionics Engineering, she previously held key roles at Oncompass Medicine, including Product Owner and Interpretation Team Leader. Her work ensures Genomate aligns with the needs of clinicians and patients in precision oncology.

Alina Luchian leads marketing, communications, and brand at Genomate Health. With over a decade of experience in SaaS and a background in strategic storytelling, she has shaped Genomate Health’s identity from the ground up. Her work helps the company connect with and reach patients and oncologists worldwide.

Dr. Edit Várkondi is a molecular medicine expert with nearly 20 years of experience in molecular diagnostics, bioinformatics, and diagnostic innovation. During her 17-year tenure at Oncompass Medicine, she played a key role in building the company's molecular diagnostic capabilities, laboratory operations, and global partner network. Today, she leads diagnostic strategy, service delivery, and international laboratory partnerships at Oncompass Medicine, a Genomate Health company.

Julia Deri, MSc, is a certified genetic counselor and precision oncology expert with more than 20 years of experience in cancer genetics and molecular interpretation. At Oncompass Medicine, a Genomate Health company, she helps patients and physicians navigate molecular testing results and complex treatment decisions. She has extensive experience in hereditary cancer risk assessment, molecular profiling, and the clinical interpretation of genomic data.

Dr. Beck is a Professor Emeritus at UIC with 50+ years in molecular pharmacology. A leader in cancer research, he’s advised the NIH, the AACR, and pioneered drug resistance studies and therapeutic target discovery in ovarian and breast cancers.

Irving Levy is a seasoned financial leader with nearly 40 years of experience in healthcare, startups, and philanthropy. He played a key role in scaling Exigence Group to $120M, led its sale to TeamHealth, and now advises Genomate Health and early-stage ventures.